Doody RS, Skerjanec S. Viewpoint: What Is Reasonable and Necessary for People Living with AD after the FDA Approves a Treatment?. J Prev Alzheimers Dis. 2023;10(3):344-345. PubMed.

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.